344 related articles for article (PubMed ID: 2697181)
21. Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells.
Theodorescu D; Cornil I; Sheehan C; Man MS; Kerbel RS
Cancer Res; 1991 Aug; 51(16):4486-91. PubMed ID: 1868471
[TBL] [Abstract][Full Text] [Related]
22. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
[TBL] [Abstract][Full Text] [Related]
23. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
24. Characterization of growth factors in human ovarian carcinomas.
Bauknecht T; Kiechle M; Bauer G; Siebers JW
Cancer Res; 1986 May; 46(5):2614-8. PubMed ID: 3008995
[TBL] [Abstract][Full Text] [Related]
25. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
Davidson B; Reich R; Goldberg I; Gotlieb WH; Kopolovic J; Berner A; Ben-Baruch G; Bryne M; Nesland JM
Clin Cancer Res; 2001 Mar; 7(3):551-7. PubMed ID: 11297247
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression.
Dotzlaw H; Miller T; Karvelas J; Murphy LC
Cancer Res; 1990 Jul; 50(14):4204-8. PubMed ID: 2364377
[TBL] [Abstract][Full Text] [Related]
27. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
Christensen ME
Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor-immunohistochemical detection and clinical significance for treatment of primary breast cancer.
Schroeder W; Biesterfeld S; Zillessen S; Rath W
Anticancer Res; 1997; 17(4A):2799-802. PubMed ID: 9252718
[TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
Mathur RS; Mathur SP
Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
[TBL] [Abstract][Full Text] [Related]
31. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
Burgart LJ; Robinson RA; Haddad SF; Moore SA
Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
[TBL] [Abstract][Full Text] [Related]
32. EGF-R and PCNA expression in ovarian carcinomas--correlation with classic prognostic factors.
Minguillon C; Schönborn I; Reles A; Bartel U; Lichtenegger W
Gen Diagn Pathol; 1996 Mar; 141(3-4):197-201. PubMed ID: 8705783
[TBL] [Abstract][Full Text] [Related]
33. Relationships between epidermal growth factor receptor (EGF-R) and other predictors of prognosis in breast carcinomas. An immunohistochemical study.
Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
Pathologica; 1993; 85(1100):637-44. PubMed ID: 8170712
[TBL] [Abstract][Full Text] [Related]
34. High levels of c-myc protein in human breast tumours determined by a sensitive ELISA technique.
Spandidos DA; Field JK; Agnantis NJ; Evan GI; Moore JP
Anticancer Res; 1989; 9(4):821-6. PubMed ID: 2683996
[TBL] [Abstract][Full Text] [Related]
35. Neuroblastoma: inverse relationship between expression of N-myc and NGF-r.
Christiansen H; Christiansen NM; Wagner F; Altmannsberger M; Lampert F
Oncogene; 1990 Mar; 5(3):437-40. PubMed ID: 2156211
[TBL] [Abstract][Full Text] [Related]
36. Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas.
Petrides PE; Bock S; Bovens J; Hofmann R; Jakse G
Cancer Res; 1990 Jul; 50(13):3934-9. PubMed ID: 2354442
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
38. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies.
Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S
Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241
[TBL] [Abstract][Full Text] [Related]
39. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]